November 2, 2016
BioTelemetry, Inc. (NASDAQ:BEAT), today reported results for the third quarter ended September 30, 2016. Company Highlights include: Recognized highest quarterly revenue in Company’s history of $53.1 million, a 22% increase over the prior year. Recorded $4.1 million GAAP net income for the third quarter. Realized highest quarterly adjusted EBITDA in Company’s history of $12.2 million, a 40% increase over the prior year. Experienced 9% year over year growth in patient volume and much more.